Document is current
Any future updates will be listed below
-
Authors
Colonna, Marco https://orcid.org/0000-0001-5222-4987
Konopka, Genevieve https://orcid.org/0000-0002-3363-7302
Liddelow, Shane A. https://orcid.org/0000-0002-0840-1437
Nowakowski, Tomasz https://orcid.org/0000-0003-2345-4964
Awatramani, Rajeshwar https://orcid.org/0000-0002-0713-2140
Bateup, Helen S. https://orcid.org/0000-0002-0135-0972
Cadwell, Cathryn R. https://orcid.org/0000-0003-1963-8285
Caglayan, Emre https://orcid.org/0000-0001-5340-8614
Chen, Jerry L. https://orcid.org/0000-0002-7409-7859
Gillis, Jesse https://orcid.org/0000-0002-0936-9774
Kampmann, Martin https://orcid.org/0000-0002-3819-7019
Krienen, Fenna https://orcid.org/0000-0002-1400-6820
Marsh, Samuel E. https://orcid.org/0000-0002-3012-6945
Monje, Michelle https://orcid.org/0000-0002-3547-237X
O’Dea, Michael R. https://orcid.org/0000-0002-6135-7607
Patani, Rickie https://orcid.org/0000-0002-3825-7675
Pollen, Alex A. https://orcid.org/0000-0003-3263-8634
Quintana, Francisco J. https://orcid.org/0000-0001-8156-0736
Scavuzzo, Marissa
Schmitz, Matthew
Sloan, Steven A. https://orcid.org/0000-0001-7769-7684
Tesar, Paul J. https://orcid.org/0000-0003-1532-3155
Tollkuhn, Jessica https://orcid.org/0000-0001-5991-7620
Tosches, Maria Antonietta https://orcid.org/0000-0001-6338-9357
Urbanek, Madeleine E.
Werner, Jonathan M. https://orcid.org/0000-0001-9248-6420
Bayraktar, Omer A. https://orcid.org/0000-0001-6055-277X
Gokce, Ozgun https://orcid.org/0000-0001-6319-404X
Habib, Naomi https://orcid.org/0000-0002-6049-2487
- License Information
-
More Information
Article History
Received: 7 November 2023
Accepted: 15 October 2024
First Online: 3 December 2024
Competing interests
: M.C. is a member of the Scientific Advisory Board of Vigil, NGMBio, Cartesian and Halyardtx. M.C. receives research support from Ono Pharmaceutical, is a consultant for CST and has patents pending on LILRB4 and TREM2. S.A.L. maintains a financial interest in AstronauTx and Synapticure and is on the Scientific Advisory Board of the Global BioAccess Fund. S.A.L. is an inventor on US Patents WO2018081250A1 and WO2022187517A1. M.K. is a co-scientific founder of Montara Therapeutics and serves on the Scientific Advisory Boards of Engine Biosciences, Casma Therapeutics, Cajal Neuroscience, Alector and Montara Therapeutics, and is an advisor to Modulo Bio and Recursion Therapeutics. M.K. is an inventor on US Patent 11,254,933 related to CRISPRi and CRISPRa screening, and on a US Patent Application on in vivo screening methods. All other authors declare no competing interests.
